With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

This was the stock's second consecutive day of losses.

Boston Scientific continues its earnings winning streak, consistently beating Wall Street expectations. In the last quarter, ...

Boston Scientific (NYSE:BSX) recently entered into a significant agreement with Bittium Biosignals Ltd. to supply ECG devices, valued between USD 30 to 45 million, which strengthens their cardiac ...

Outlook: Boston Scientific forecasts net sales growth of approximately 15%-17% in 2025 on a reported basis and around 12%-14% on an organic basis, compared to prior guidance of 12.5%-14.5% and 10% ...

Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.

For the full year, Boston Scientific sees adjusted EPS of $2.87 to $2.94 and sales up 15% to 17%, above Visible Alpha projections.

Boston Scientific has announced the appointment of Conor Russell as the new Vice President of Operations at its Galway site. Originally from Wexford, Conor joined Boston Scientific in 1999 and has ...

Boston Scientific has performed significantly well across all its business segments, reporting a 19.34% y-o-y revenue growth for Q3 2024 reaching $4.21 billion.

The Boston Globe Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back? “It’s been a brick by brick, constant improvement, strengthening ...

Since arriving into Galway, Boston Scientific also expanded to Cork and Clonmel in Co Tipperary and it is now the largest life science employer in the country, employing approximately 6,500 people – ...